T
his is the first report of
progressive familial intrahepatic cholestasis type 2 from India. The
treatment options in this condition are dictated by the stage of the
disease. Early diagnosis of this condition allowed us to use a novel
surgical approach to treat this condition and prevent or delay the
evolution of secondary cirrhosis, and possible need for liver
transplantation.
Case Report
A one month old girl presented to our hospital with
jaundice and passage of clay colored stools. She was a product of non
consanguineous marriage, born at term by normal delivery. She was icteric,
and liver and spleen were just palpable below the subcostal margin.
Investigations revealed direct hyperbilirubinemia with serum bilirubin 7.4
mg/dL with a conjugated fraction of 5 mg/dL; serum albumin was 4.3 mg/dL,
AST was 413 IU/dL, ALT 629IU/dL, GGT 27I U/dL and prothrombin time was 18
seconds (control 14s). Ultrasound abdomen revealed coarse echotexture of
liver with a normal gall bladder and common bile duct. Hepatobiliary
immunodiacetic acid (HIDA) scan demonstrated good concentration of dye in
liver with prompt excretion into small bowel. Her TORCH screen, alfa 1
antitrypsin levels, and thyroid function tests were within normal limits.
Liver biopsy was postponed to a later date, on the request of parents. She
was discharged on ursodeoxycholic acid, phenobarbitone and multi-vitamins.
She did not return for follow-up after discharge. At 2 years of age, the
girl was readmitted with intense pruritus, skin excoriation and mild
fever. Severe itching had resulted in alopecia accreta and lichenification
of skin of hands and feet. Her liver function tests had, however, improved
(serum bilirubin total 0.3 mg/dL, conjugated 0.1mg/dL, AST 201 and ALT
532), while GGT remained normal.
A diagnosis of progressive familial intrahepatic
cholestasis was considered in view of intense pruritus due to cholestasis
and normal GGT. The liver biopsy demonstrated disruption of lobular
architecture with cholestasis and portal to portal bridging fibrosis which
was compatible with this diagnosis. To further categorize the type of PFIC,
the family sought a gene mutation analysis overseas which confirmed it to
be bile salt export pump (BSEP) defect with gene mutation ABCB 11,
confirming it to be PFIC type 2.
Despite medical therapy with ursodeoxycholic acid and
phenobarbitone, the itching persisted leading to multiple skin lesions.
Since her symptoms were refractory to medical management for more than
twenty months, surgical intervention was considered. As the liver biopsy
did not demonstrate any features of cirrhosis, it was decided to give a
trial of partial external biliary diversion (PEBD). Rather than using the
conventional method of using a jejunal loop as a conduit between the gall
bladder and abdominal wall, an appendicular graft based on Mitrofanoff
principle was used to create a cholecystoappendicostomy, and appendicular
stoma was matured in the right iliac fossa.
She had an early recovery after surgery and went on to
oral feeding on day two. The post operative recovery was satisfactory
other than a wound infection. The appendix was intubated for three weeks
after surgery as an outpatient to drain bile from gall bladder. On removal
of the tube, she was left with a 5mm size stoma in the right iliac fossa
through which she drains about 150 ml of bile every day into a stoma bag.
All oral medications have been gradually tapered. Six months following
surgery she is completely asymptomatic and her latest liver function tests
are completely within normal limit.
Discussion
PFIC, also known as Bylers disease presents in early
childhood with pruritus, jaundice, hepatomegaly and growth failure and can
progress to liver failure before adolescence due to secondary
cirrhosis(1). The diagnosis of PFIC needs a high index of suspicion. The
laboratory parameters which can aid in diagnosis are low to normal GGT,
low cholesterol and high levels of bile acids in blood(2). PFIC results
from mutations in various genes encoding hepatobiliary transport proteins.
Mutations in the FIC1 gene causes PFIC type 1. PFIC type 2 results from
mutations in the bile salt export pump (BSEP) gene. PFIC type 3 is caused
by mutations in the MDR3 gene(3). Accumulation of bile acids causes
intra-hepatic cholestasis which leads to progressive fibro-sis and
cirrhosis by the end of first decade of life.
Medical management is ineffective in interrupting the
progression of disease and in alleviating the pruritus in a majority of
the patients(4). For children with decompensated cirrhosis the only
treatment is liver transplantation(5).
Early institution of biliary drainage can delay
progression of this disease to end stage liver failure and need for liver
transplantation. Prior to 1990, liver transplantation was the only
effective therapy for these children, as in the vast majority, the disease
was detected at a more advanced stage of the disease with end stage liver
failure. A better understanding of the disease and earlier recognition has
lead to development of biliary drainage as a surgical option(6).
Pruritus can be alleviated by interrupting the
enterohepatic circulation and reducing the bile acid pool. Various
surgical techniques have been used for this. In 1998, Whitington, et al.(7)
introduced cholecystojejunocutaneostomy for partial external biliary
diversion. Though, it leads to significant clinical improvement, a stoma
care was not considered an acceptable solution for this problem.
Therefore, an attempt was made to use internal ileal bypass procedure, so
that the bile salts could bypass the terminal small bowel where they get
absorbed(8). Although initial results were encouraging but late recurrence
of symptoms and choleretic diarrhea led to revision in surgery in some
cases; this procedure is therefore not a popular option .
We performed an external drainage as the family was
willing for a stoma. Instead of jejunum we used the appendix as our choice
of conduit. This was based on the availability of a normal appendix,
preventing the need for a resection and anastomosis of small bowel and
thus reducing the stay in hospital significantly. The cosmetic appearance
of an appendicular stoma, the position below the waist line and
possibility of intubating the stoma for drainage were other obvious
advantages(9,10).
Contributors: UHS was primarily responsible for
managing the patient under supervision and performed review of literature.
DS wrote the initial draft of the manuscript along with UHS. AS and SKC
were responsible for supervising the management of the patient, surgery
and revised the manuscript.
Funding: None.
Competing interests: None stated.
References
1. Jacquemin E. Progressive familial intrahepatic
cholestasis. J Gastroenterol Hepatol 1999; 14: 594-599.
2. Whitington PF, Freese DK, Alonso EM, Schwarzenberg
SJ, Sharp HL. Clinical and biochemical findings in progressive familial
intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994; 18: 134-141.
3. Jansen PL, Sturm E. Genetic cholestasis, causes and
consequences for hepatobiliary transport. Liver Int 2003; 23: 315-322.
4. Narkewicz MR, Smith D, Gregory C, Lear JL, Osberg I,
Sokol RJ. Effect of ursodeoxycholic acid therapy on hepatic function in
children with intrahepatic cholestasic liver disease. J Pediatr
Gastroenterol Nutr 1998; 26: 49-55.
5. Englert C, Grabhorn E, Richter A, Rogiers X,
Burdelski M, Ganschow R. Liver transplantation in children with
progressive familial intrahepatic cholestasis. Transplantation 2007; 84:
1361-1363.
6. Kalichinski PJ, Ismail H, Jankowska I, Kaminski A,
Pawlowska J, Drewniak T, et al. Surgical treatment of progressive
familial intrahepatic cholestasis: comparision of partial external biliary
diversion and ileal bypass. Eur J Pediatr Surg 2003; 13: 307-311.
7. Whitington PF, Whitington GL. Partial external
diversion of bile for the treatment of intractable pruritus associated
with intrahepatic cholestasis. Gastroenterology 1988; 95: 130-136.
8. Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina,
Loret-de-Mola O, Nahmad M. Ileal exclusion for Byler’s disease: an
alternative surgical approach with promising early results for pruritus. J
Pediatr Surg 1998; 33: 220-224.
9. Rebhandl W, Felberbauer FX, Turnbull J, Paya K,
Barcik U, Huber WD, et al. Biliary diversion by use of the appendix
(cholecystoappendicostomy) in progressive familial intrahepatic
cholestasis. J Pediatr Gastroenterol Nutr 1999; 28: 217-219.
10. Mattie P, von Allman D, Picolo D, Rand E. Relief of
intractable pruritis in Alagille syndrome by partial external biliary
diversion. J Pediatr Surg 2006; 41: 104-107.